We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
-19.74%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$275M
AUM Growth
-$16.9M
Cap. Flow
+$40.9M
Cap. Flow %
14.91%
Top 10 Hldgs %
36.4%
Holding
93
New
30
Increased
20
Reduced
14
Closed
25

Top Buys

Rank Stock Value
1
COR icon
Cencora
COR
+$11.5M
2
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$11M
3
CVS icon
CVS Health
CVS
+$10.8M
4
MDT icon
Medtronic
MDT
+$8.96M
5
CAH icon
Cardinal Health
CAH
+$7.66M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$14.6M
2
AET
Aetna Inc
AET
+$12.3M
3
KURA icon
Kura Oncology
KURA
+$7.72M
4
BIIB icon
Biogen
BIIB
+$6.82M
5
ELV icon
Elevance Health
ELV
+$6.8M

Sector Composition

Rank Sector Weight
1 Healthcare 91.02%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EBS icon
26
Emergent Biosolutions
EBS
$375M
$4.37M 1.59%
73,793
+31,994
+77% +$2.06M
PEN icon
27
PUT
Penumbra
PEN
$12.6B
$4.16M 1.51%
+34,000
New +$4.55M
FOMX
28
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$4.13M 1.51%
1,151,510
+381,510
+50% +$1.66M
VTAK icon
29
Catheter Precision
VTAK
$1M
$3.87M 1.41%
2
+1
+100% +$2.36M
SNN icon
30
Smith & Nephew
SNN
$13.6B
$3.82M 1.39%
102,163
-32,225
-24% -$1.16M
ALGN icon
31
Align Technology
ALGN
$12.4B
$3.74M 1.36%
+17,847
New +$4.51M
ZBH icon
32
Zimmer Biomet
ZBH
$18.4B
$3.65M 1.33%
+36,198
New +$4.07M
BDX icon
33
Becton Dickinson
BDX
$45.6B
$3.6M 1.31%
+16,400
New +$3.81M
UNH icon
34
UnitedHealth
UNH
$383B
$3.54M 1.29%
14,207
+1,628
+13% +$430K
ABT icon
35
Abbott
ABT
$183B
$3.52M 1.28%
48,737
+34,517
+243% +$2.43M
RVNC
36
DELISTED
Revance Therapeutics, Inc.
RVNC
$3.38M 1.23%
167,724
+3,371
+2% +$74.3K
MEDP icon
37
Medpace
MEDP
$16.1B
$3.34M 1.22%
+63,180
New +$3.47M
AMGN icon
38
Amgen
AMGN
$209B
$3.31M 1.21%
+17,000
New +$3.32M
UTHR icon
39
United Therapeutics
UTHR
$26.2B
$3.27M 1.19%
+30,000
New +$3.48M
ICLR icon
40
Icon
ICLR
$12.8B
$2.79M 1.02%
21,566
-1,632
-7% -$225K
RVLP
41
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$2.69M 0.98%
+346,410
New +$2.77M
BMY icon
42
Bristol-Myers Squibb
BMY
$132B
$2.6M 0.95%
+50,000
New +$2.69M
STRO icon
43
Sutro Biopharma
STRO
$411M
$2.54M 0.93%
28,191
+4,937
+21% +$596K
XRAY icon
44
Dentsply Sirona
XRAY
$2.75B
$2.44M 0.89%
+65,666
New +$2.39M
GYRE icon
45
Gyre Therapeutics
GYRE
$648M
$2.3M 0.84%
38,883
-34,581
-47% -$2.55M
HRC
46
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$2.19M 0.8%
24,682
+646
+3% +$58.7K
KURA icon
47
Kura Oncology
KURA
$826M
$2.03M 0.74%
144,411
-582,847
-80% -$7.72M
HROW icon
48
Harrow
HROW
$1.45B
$1.91M 0.7%
+335,364
New +$1.44M
FRTX
49
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$1.91M 0.69%
5,130
+1,194
+30% +$468K
CCXI
50
DELISTED
ChemoCentryx, Inc.
CCXI
$1.85M 0.67%
+169,257
New +$1.78M
1
2
3 4

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Sio Capital Management held 93 positions worth $275M, down 5.8% from $291M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Sio Capital Management deployed $40.9M of net new capital in Q4 2018, opening 30 new positions and adding to 20 existing holdings. Its largest new stake was Cencora: 133,934 shares worth $9.96M.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, up from 75% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Kura Oncology, an estimated $7.72M trimmed.

  • Sio Capital Management's largest Q4 2018 buy was Cencora: 133,934 shares worth $9.96M.
  • Sio Capital Management added most to Medtronic in Q4 2018, an estimated $8.96M increase.
  • Sio Capital Management's biggest Q4 2018 reduction was Kura Oncology, cutting an estimated $7.72M.
  • Sio Capital Management fully exited GSK in Q4 2018, selling an estimated $14.6M.
  • Sio Capital Management's ten largest holdings make up 36% of its $275M portfolio in Q4 2018.
  • Sio Capital Management opened 30 new positions and closed 25 in Q4 2018.
  • Sio Capital Management's portfolio value fell 5.8% quarter-over-quarter to $275M.

Based on Sio Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.